Antithrombotic Properties of SSR182289A, a New, Orally Active Thrombin InhibitorJ Lorrain, Stephen E. O'Connor, M. Sainte-Marie et al.|Journal of Pharmacology and Experimental Therapeutics|2003Cited by 23
Effect of SanOrg123781A, a synthetic hexadecasaccharide, on clot-bound thrombin and factor Xa in vitro and in vivoJ-P. Hérault, J‐M. Herbert, M. Cappelle et al.|Journal of Thrombosis and Haemostasis|2003Cited by 14
SSR182289A enhances thrombolysis induced by fibrinolytic agents in rabbit models of venous and arterial thrombosisC. Visconte, J‐M. Herbert, Paul Schaeffer et al.|Journal of Thrombosis and Haemostasis|2004Cited by 3